SCHEMBL8790193

SCHEMBL8790193

COc1ccc(CN(C)CCc2cccc(NC(=O)c3cccc4c(=O)c5cccc(F)c5[nH]c34)c2)cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 3/20 0.51
▸ ABCB1 P08183 2/20 0.48
▸ ALOX5 P09917 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ BACE1 P56817 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ TP53 P04637 2/20 0.42
▸ OPRM1 P35372 2/20 0.42
▸ TMEM97 Q5BJF2 2/20 0.42
▸ SIGMAR1 Q99720 2/20 0.42
▸ OPRK1 P41145 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ GUSB P08236 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8791638 0.96 ABCG2 (0.51) ABCG2ABCB1ALOX5ACHEBACE1
SCHEMBL8789595 0.94 ABCG2 (0.54) ABCG2ABCB1ACHEKDM4ECYP1A2
SCHEMBL8790240 0.93 ABCG2 (0.55) ABCG2ABCB1ALOX5ACHEBACE1
SCHEMBL8790784 0.91 ABCG2 (0.52) ABCG2ABCB1KDM4ECYP1A2CYP3A4
SCHEMBL8789137 0.91 ABCG2 (0.52) ABCG2ABCB1KDM4ECYP1A2CYP3A4
SCHEMBL8790232 0.90 ABCG2 (0.54) ABCG2ABCB1ACHECYP3A4TP53
SCHEMBL8792324 0.89 ABCG2 (0.50) ABCG2ABCB1KDM4ECYP1A2CYP3A4
SCHEMBL8789279 0.89 ABCG2 (0.53) ABCG2ABCB1ACHECYP3A4TP53
SCHEMBL8790604 0.89 ABCG2 (0.54) ABCG2ABCB1ALOX5ACHEBACE1
SCHEMBL8789907 0.88 ABCG2 (0.52) ABCG2ABCB1ACHECYP3A4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569380-B1 ACRIDINE DERIVATIVES GLAXO LAB SA (FR) 1997-05-28 — — EP disclosed
US-5604237-A IMPROVE OR INCREASE EFFICACY OF ANTITUMOR AGENT, INCREASE OR RESTORE SENSITIVITY OF TUMOR TO ANTITUMOR AGENT, REVERSE OR REDUCE RESISTANCE OF TUMOR TO ANTITUMOR AGENT LABORATOIRES GLAXO SA (FR) 1997-02-18 — — US disclosed
EP-0494623-A1 Acridine derivatives LABORATOIRES GLAXO SA (FR) 1992-07-15 — — EP disclosed
Send feedback